≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

Endpoint Browser PheWeb

C3_PERIPHERAL_NERVES_AUTONOMIC3_NERVESYSTEM_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C47
  • Hospital discharge: ICD-9 — 1928
  • Hospital discharge: ICD-8 — 192[4-5]
  • Cause of death: ICD-10 — C47
  • Cause of death: ICD-9 — 1928
  • Cause of death: ICD-8 — 192[4-5]
  • Cancer registry: Topography ICD-O-3 — C47
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

133

4. Check minimum number of events

None

133

5. Include endpoints

None

133

6. Filter based on genotype QC (FinnGen only)

127

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 127 65 62
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 52.51 49.90 55.25

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
133
Matched controls
1330
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
47.8
43
*
H02AB02
ATC
dexamethasone; systemic
95.8
28.1
30
*
JN4AD
NOMESCO Finland
Body CT examination
10.8
24.7
30
35
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
290.1
24.5
24
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
20.0
20.0
30
19
C47.30
ICD-10 Finland
Malignant tumor of peripheral nerves of the thorax without histology
+∞
18.1
17
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.8
17.9
41
95
TPH07
NOMESCO Finland
Cathetrisation of artery
6.6
16.3
30
56
ZXE20
NOMESCO Finland
More than three and less than five hours
5.4
15.2
36
85
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
17.3
14.2
22
15
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
13.8
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
13.8
13
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.8
13
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
155.2
13.7
14
*
A04AA02
ATC
granisetron; systemic, transdermal
155.2
13.7
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
13.1
84
407
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
12.7
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.7
12
*
L03AA02
ATC
filgrastim; parenteral
+∞
12.7
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.7
12
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
12.7
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
142.9
12.7
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
12.2
11.8
21
20
WF002
NOMESCO Finland
Radical radiotherapy
130.9
11.6
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
10.9
50
191
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
65.4
10.8
12
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
119.0
10.6
11
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
10.6
10
*
C47.16
ICD-10 Finland
Malignant tumor of the peripheral nerves of the upper extremity including the shoulder neurilemmoma
+∞
10.6
10
*
JN4BD
NOMESCO Finland
Extensive body CT
9.8
10.5
21
25
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.5
10.4
22
46
WZC00
NOMESCO Finland
Treatment plan or consultation
3.3
10.1
58
253
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
59.4
9.8
11
*
ZZR00
NOMESCO Finland
Flap of skin
107.3
9.5
10
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
107.3
9.5
10
*
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
9.5
9
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
9.5
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
9.2
63
301
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
20.4
9.1
13
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.4
8.9
19
40
Z3226
NOMESCO Finland
Physiotherapist
3.3
8.7
41
157
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
8.5
38
140
C47.39
ICD-10 Finland
Malignant tumor of peripheral nerves of the thorax other or unspecified tumor
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
C47.3
ICD-10 Finland
Malignant neoplasm: Peripheral nerves of thorax
+∞
8.4
8
*
9500/3-C47.3
ICD-O-3
Neuroblastoma, NOS, of peripheral nerves and autonomic nervous system of thorax
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
A04AA01
ATC
ondansetron; systemic, rectal
11.9
8.0
14
13
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
7.6
25
75
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
14.5
7.5
12
9
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.4
7
*
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
+∞
7.4
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.4
7
*
19251
ICD-8 Finland
Malignant neoplasm of other part of nervous system, Sympathetic nervous system
+∞
7.4
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.4
7
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
7.4
7
*
C47.00
ICD-10 Finland
Malignant tumor of the peripheral nerves of the head, face and neck without histology
+∞
7.4
7
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
7.4
7
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
7.3
33
122
XX3DW
NOMESCO Finland
Time consuming IT work
7.7
7.3
16
23
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
31.9
7.2
9
*
WW500
NOMESCO Finland
Blood transfusion
13.0
7.2
12
10
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
7.4
7.1
16
24
Z3231
NOMESCO Finland
Registered nurse
2.8
6.8
46
213
XW000
NOMESCO Finland
Bone marrow biopsy
13.2
6.7
11
9
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.2
6.7
11
9
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
13.2
6.7
11
9
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
15.3
6.5
10
7
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
73.2
6.5
7
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
6.4
25
84
9500/3-C47.4
ICD-O-3
Neuroblastoma, NOS, of peripheral nerves and autonomic nervous system of abdomen
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
6.3
6
*
9560/3-C47.9
ICD-O-3
Neurilemoma, malignant of autonomic nervous system, NOS
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
C47.19
ICD-10 Finland
Malignant tumor of the peripheral nerves of the upper extremity including the shoulder other or unspecified tumor
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
6.3
6
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
6.2
36
152
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.3
6.2
12
14
G47.3
ICD-10 Finland
Sleep apnoea
2.7
6.1
40
181

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
25
34
8.82
18.04
1.5
1.1
—
—
—
0
0
73
348
3.43
11.21
2.6
1.6
—
—
—
0
0
41
146
3.61
9.81
8.1
10.3
105.83
104.55
mmol/l
1.03
41
146
57
269
2.96
8.36
4.3
4.1
—
—
—
0
0
63
322
2.82
7.87
2.9
2.1
—
—
—
0
0
11
6
19.79
7.74
4.9
1.5
18.47
14.86
ug/l
—
11
6
32
112
3.45
7.72
7.3
10.5
7.40
7.42
ph
0.75
17
59
30
101
3.54
7.68
1.4
1.1
—
—
—
0
0
88
540
2.86
7.64
10.1
7.3
1.19
1.21
mmol/l
1.69
82
469
78
455
2.73
7.39
3.1
2.4
—
—
estimate
—
0
0
65
348
2.70
7.29
4.4
3.3
24.33
37.62
e6/l
0.55
53
262
52
259
2.65
6.61
4.6
3.6
93.06
90.27
%
0.34
52
254
78
478
2.53
6.36
13.3
11.2
1.22
1.23
inr
0.06
61
396
69
403
2.48
6.19
5.0
4.0
43.36
56.87
e6/l
0.19
54
277
92
621
2.56
5.92
12.3
6.0
4.34
4.34
e9/l
0.00
84
517
33
146
2.68
5.17
2.4
1.8
—
—
—
0
0
57
327
2.30
5.09
5.2
3.1
7.40
7.40
ph
0.06
39
220
39
197
2.39
4.60
3.9
3.0
528.52
557.39
mosm/kgh2o
0.29
33
171
57
340
2.18
4.52
5.6
2.0
2.36
2.36
mmol/l
0.02
49
302
19
68
3.09
4.33
8.3
15.0
0.64
0.67
%
0.13
19
68
19
70
3.00
4.13
8.3
14.7
1.18
1.49
%
0.60
19
70
10
18
5.91
4.06
2.5
1.6
19.35
23.37
ng/l
—
10
18
51
302
2.12
4.04
4.9
3.2
0.30
0.23
e6/l
0.25
40
213
83
593
2.06
3.91
7.7
5.4
1.85
1.89
e9/l
0.14
75
512
20
79
2.80
3.84
5.1
3.8
1.43
0.83
%
—
7
12
24
105
2.57
3.80
8.0
12.5
—
—
—
0
0
14
45
3.36
3.77
4.0
3.2
36.86
36.86
°c
0.01
14
45
19
75
2.79
3.65
5.5
3.9
1.14
0.33
%
—
7
12
15
53
3.06
3.49
3.0
1.5
2.16
2.53
ug/l
—
10
38
7
10
7.31
3.41
5.1
1.1
11.14
9.10
mmol/l
—
7
10
80
583
1.93
3.35
7.8
5.4
0.56
0.58
e9/l
0.30
71
485
14
49
3.08
3.30
5.1
3.4
—
—
—
0
0
20
86
2.56
3.27
7.3
18.7
24.44
25.39
mmol/l
0.69
20
86
19
80
2.60
3.23
6.9
4.0
1.50
0.00
%
—
6
10
80
588
1.90
3.22
7.7
5.4
0.04
0.04
e9/l
1.59
71
488
27
135
2.25
3.19
5.1
5.7
7.38
7.38
ph
0.17
14
77
17
68
2.72
3.19
1.4
1.4
—
—
—
0
0
6
8
7.78
3.08
2.5
3.3
4.63
6.64
nmol/l
—
6
8
5
5
10.32
3.00
1.0
1.6
98.80
69.00
nmol/l
—
5
5
81
606
1.86
3.00
8.2
5.4
0.21
0.20
e9/l
0.06
72
512
56
375
1.85
2.95
3.5
3.5
—
—
—
0
0
18
79
2.48
2.82
5.4
3.8
0.20
0.08
%
—
5
12
21
101
2.28
2.71
3.6
2.0
75.52
66.84
e9/l
0.47
16
71
50
331
1.82
2.68
9.0
4.1
—
—
—
0
0
31
176
1.99
2.64
4.4
3.2
2.46
2.20
e6/l
0.06
17
77
54
371
1.77
2.54
7.0
5.1
—
—
—
0
0
10
32
3.29
2.49
1.3
1.0
—
—
—
0
0
59
421
1.72
2.40
3.9
3.7
44.18
42.96
ng/l
0.02
44
306
22
114
2.11
2.37
2.7
1.9
362.64
397.45
nmol/l
0.37
22
108
18
86
2.26
2.36
4.6
7.7
24.44
24.29
mmol/l
0.09
18
86
47
316
1.75
2.35
4.5
2.7
—
—
—
0
0
89
714
1.75
2.34
6.1
4.3
—
402.11
—
0
9
8
23
3.63
2.31
1.3
1.2
—
—
—
0
0
5
9
5.72
2.23
1.4
1.1
—
—
—
0
0
17
82
2.23
2.18
7.2
4.9
66.68
90.22
ng/l
0.99
17
67
69
524
1.66
2.16
13.6
9.0
0.06
0.00
e9/l
0.49
57
413
5
11
4.68
1.96
1.4
2.6
0.80
0.73
index
—
5
11
6
16
3.87
1.96
7.0
5.2
12.75
10.64
mg/l
—
6
16
42
288
1.67
1.91
2.9
2.3
2.71
2.48
mg/l
0.31
37
240
5
13
3.95
1.73
2.8
1.5
—
—
nmol/l
—
0
0
35
235
1.66
1.71
1.5
1.7
1.68
1.14
mg/l
0.27
23
186
6
19
3.26
1.68
1.2
1.4
—
—
—
0
0
7
25
2.90
1.67
6.4
3.8
3.84
3.82
mmol/l
—
7
25
34
229
1.65
1.64
5.4
4.6
—
—
—
0
0
100
865
1.63
1.62
5.1
4.2
14.94
14.92
pmol/l
0.03
91
784
5
15
3.42
1.53
3.0
2.7
—
—
—
0
0
14
73
2.03
1.50
1.4
1.3
—
—
—
0
0
72
586
1.50
1.49
4.3
3.6
0.00
0.00
estimate
—
10
105
5
16
3.20
1.45
1.6
1.4
38.95
238.80
u/ml
—
5
16
71
581
1.48
1.40
4.3
3.6
0.00
0.00
estimate
-0.00
13
118
60
478
1.47
1.34
3.7
3.3
6.37
6.25
ph
0.25
30
267
26
173
1.63
1.31
1.6
1.7
925.21
1154.52
nmol/l
0.63
21
130
5
19
2.69
1.22
1.0
1.4
—
—
—
0
0
69
575
1.42
1.17
4.2
3.6
0.00
0.00
estimate
-0.00
13
117
45
349
1.44
1.12
3.1
2.2
112.02
204.85
u/l
1.63
45
327
7
34
2.12
1.04
1.6
1.2
—
—
—
0
0
9
48
1.94
1.03
1.1
1.1
—
—
—
0
0
118
1102
1.63
0.97
23.8
13.0
27.28
23.89
mg/l
0.65
111
864
85
751
1.37
0.93
5.1
3.9
—
—
—
0
0
6
29
2.12
0.90
4.5
1.7
—
—
—
0
0
42
336
1.37
0.86
7.3
4.0
2.24
1.89
ug/l
0.25
36
300
6
32
1.92
0.83
2.3
2.7
7.41
7.40
ph
—
6
32
0
25
0.00
0.80
0.0
5.4
—
36.11
—
0
18
110
1027
1.41
0.74
6.2
5.2
1.98
1.90
mu/l
0.29
99
938
20
144
1.46
0.73
1.6
1.8
—
—
—
0
0
7
40
1.79
0.72
1.3
1.3
1.25
1.10
g/l
—
7
40
10
61
1.69
0.70
1.7
6.3
0.51
0.55
%
—
10
61
5
27
1.88
0.69
3.2
3.3
—
—
—
0
0
119
1132
1.49
0.66
21.9
11.0
—
—
—
0
0
10
63
1.64
0.64
1.7
6.1
0.96
1.10
%
—
10
63
0
21
0.00
0.60
0.0
1.1
—
3.63
—
0
16
16
115
1.44
0.60
1.6
1.3
—
—
—
0
0
6
36
1.70
0.57
7.3
7.6
—
—
—
0
0
6
37
1.65
0.56
1.0
1.1
—
—
—
0
0
36
299
1.28
0.56
4.6
3.8
0.00
0.00
estimate
—
9
105
39
330
1.26
0.52
1.7
1.6
17.44
22.07
nmol/l
1.34
32
278
6
40
1.52
0.52
1.2
1.3
0.21
0.22
g/l
—
6
40
10
67
1.53
0.51
4.3
3.6
218.60
246.40
ng/l
—
10
62
109
1034
1.30
0.51
5.9
6.8
38.41
39.58
mmol/mol
0.74
101
975
57
506
1.22
0.49
2.2
2.0
83.73
97.23
pmol/l
1.55
28
238
108
1025
1.29
0.48
4.6
4.3
1.27
1.23
mmol/l
0.24
98
937
5
81
0.60
0.47
1.2
2.2
3.12
3.54
mmol/l
—
5
69
11
77
1.47
0.47
1.2
2.1
10.28
10.31
g/l
0.01
11
72
18
140
1.33
0.45
1.9
1.5
—
—
—
0
0
47
415
1.20
0.42
4.1
3.5
6.28
7.76
mmol/l
2.65
39
345
14
107
1.34
0.39
1.4
1.5
—
—
—
0
0
112
1076
1.26
0.38
5.3
5.2
4.40
4.53
mmol/l
0.68
105
1005
17
210
0.78
0.37
1.5
1.3
29.12
27.67
iu/ml
—
5
64
27
309
0.84
0.29
1.7
1.5
—
—
—
0
0
8
62
1.31
0.28
4.9
8.3
—
—
—
0
0
25
287
0.84
0.28
1.2
1.5
0.84
1.19
u/ml
—
5
72
42
380
1.15
0.28
3.5
3.5
79.97
67.79
mg/l
0.11
26
247
29
256
1.17
0.26
5.3
3.6
1.01
1.02
kg/l
1.28
20
159
22
253
0.84
0.25
1.1
1.4
2.31
2.41
g/l
0.07
11
136
43
394
1.14
0.24
3.7
4.2
11.76
12.18
mg/mmol
0.02
26
244
5
38
1.33
0.23
1.0
1.2
1.50
1.54
g/l
—
5
38
5
38
1.33
0.23
1.0
1.2
0.73
0.98
g/l
—
5
38
14
117
1.22
0.21
1.8
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
110
1072
1.15
0.20
5.1
5.1
1.40
1.46
mmol/l
0.78
101
994
7
58
1.22
0.18
2.0
1.7
—
—
—
0
0
16
183
0.86
0.17
1.6
1.3
19.03
7.65
u/ml
—
7
58
10
120
0.82
0.17
1.9
2.0
—
—
—
0
0
5
65
0.76
0.17
1.4
1.6
1.10
1.16
g/l
—
5
58
109
1065
1.13
0.16
5.8
5.0
5.89
5.96
mmol/l
0.31
101
975
38
408
0.90
0.16
3.3
3.6
—
—
—
0
0
24
217
1.13
0.16
1.7
1.7
383333823.17
451.18
pmol/l
0.48
18
175
13
150
0.85
0.15
1.5
1.2
—
—
—
0
0
9
107
0.83
0.13
1.1
1.2
—
—
—
0
0
12
137
0.86
0.12
1.5
1.5
—
—
—
0
0
46
437
1.08
0.12
4.7
3.5
0.00
0.00
estimate
—
10
92
10
86
1.18
0.11
1.0
1.3
—
—
—
0
0
6
54
1.12
0.09
1.0
1.1
—
—
—
0
0
18
166
1.10
0.08
2.4
1.8
—
—
—
0
0
23
219
1.06
0.04
2.0
2.1
—
—
—
0
0
110
1090
1.05
0.03
6.1
6.0
2.53
2.65
mmol/l
0.69
101
1016
48
471
1.03
0.02
1.8
2.1
1.58
1.33
mmol/l
0.92
40
391
19
186
1.03
0.00
2.9
2.7
0.95
0.71
ug/l
0.64
11
122
0
7
0.00
-0.00
0.0
1.0
—
391.00
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
11.1
—
0.65
—
0
7
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.5
—
1646.25
—
0
8
32
320
1.00
-0.00
4.7
3.0
0.00
0.00
estimate
—
9
88
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
73.13
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
114.90
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
112.14
—
0
7
7
74
0.94
-0.00
6.0
3.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
12.7
—
851.14
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_PERIPHERAL_NERVES_AUTONOMIC3_NERVESYSTEM_WIDE – Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).